Literature DB >> 17671515

Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.

Mao-Qiang Man1, Yutaka Hatano, Seung H Lee, Mona Man, Sandra Chang, Kenneth R Feingold, Donald Y M Leung, Walter Holleran, Yoshikazu Uchida, Peter M Elias.   

Abstract

Atopic dermatitis (AD) is a chronic dermatosis bearing clinical, histological, and immunologic similarities to chronic allergic contact dermatitis (ACD). AD shows a Th2 cell-dominant inflammatory infiltrate, elevated serum IgE levels, a permeability barrier abnormality, and Staphylococcus aureus colonization. Repeated hapten challenges reportedly produce a Th2-like hypersensitivity reaction (Th2-like HR). Here, 9-10 challenges with oxazolone (Ox) to hairless mice also produced a chronic Th2-like HR. Permeability barrier function and expression of differentiation proteins, filaggrin, loricrin, and involucrin, became abnormal. CRTH-positive Th2-dominant inflammatory infiltrate, with increased IL-4 expression, and a large increase in serum IgE levels were observed. The barrier abnormality was associated with decreased stratum corneum (SC) ceramide content and impaired lamellar body secretion, resulting in abnormal lamellar membranes, as in human AD. Furthermore, as in human AD, epidermal serine protease activity in SC increased and expression of two lamellar body-derived antimicrobial peptides, CRAMP and mBD3, declined after Ox challenges, paralleling the decrease of their human homologues in AD. Thus, multiple Ox challenges to normal murine skin produce a chronic Th2-like HR, with multiple features of human AD. Because of its reproducibility, predictability, and low cost, this model could prove useful for evaluating both pathogenic mechanisms and potential therapies for AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671515      PMCID: PMC2671229          DOI: 10.1038/sj.jid.5701011

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  64 in total

1.  Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema.

Authors:  O Bleck; D Abeck; J Ring; U Hoppe; J P Vietzke; R Wolber; O Brandt; V Schreiner
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

2.  Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis.

Authors:  Peck Y Ong; Qutayba A Hamid; Jeffrey B Travers; Ian Strickland; Muhamed Al Kerithy; Mark Boguniewicz; Donald Y M Leung
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

3.  IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity.

Authors:  S Nakae; C Naruse-Nakajima; K Sudo; R Horai; M Asano; Y Iwakura
Journal:  Int Immunol       Date:  2001-12       Impact factor: 4.823

4.  Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis.

Authors:  A Aioi; H Tonogaito; H Suto; K Hamada; C R Ra; H Ogawa; H Maibach; H Matsuda
Journal:  Br J Dermatol       Date:  2001-01       Impact factor: 9.302

5.  Effects of dietary restriction on spontaneous dermatitis in NC/Nga mice.

Authors:  W Fan; K Kouda; H Nakamura; H Takeuchi
Journal:  Exp Biol Med (Maywood)       Date:  2001-12

6.  Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice.

Authors:  J C Chan; D A Duszczyszyn; F J Castellino; V A Ploplis
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

7.  Gene polymorphism in Netherton and common atopic disease.

Authors:  A J Walley; S Chavanas; M F Moffatt; R M Esnouf; B Ubhi; R Lawrence; K Wong; G R Abecasis; E Y Jones; J I Harper; A Hovnanian; W O Cookson
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

8.  Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis.

Authors:  L S Chan; N Robinson; L Xu
Journal:  J Invest Dermatol       Date:  2001-10       Impact factor: 8.551

9.  Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models.

Authors:  Mary Y Sheu; Ashley J Fowler; Jack Kao; Matthias Schmuth; Kristina Schoonjans; Johan Auwerx; Joachim W Fluhr; Mao-Qiang Man; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2002-01       Impact factor: 8.551

10.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.

Authors:  Colin N A Palmer; Alan D Irvine; Ana Terron-Kwiatkowski; Yiwei Zhao; Haihui Liao; Simon P Lee; David R Goudie; Aileen Sandilands; Linda E Campbell; Frances J D Smith; Gráinne M O'Regan; Rosemarie M Watson; Jo E Cecil; Sherri J Bale; John G Compton; John J DiGiovanna; Philip Fleckman; Sue Lewis-Jones; Gehan Arseculeratne; Ann Sergeant; Colin S Munro; Brahim El Houate; Ken McElreavey; Liselotte B Halkjaer; Hans Bisgaard; Somnath Mukhopadhyay; W H Irwin McLean
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

View more
  89 in total

1.  Cutaneous resonance running time varies with age, body site and gender in a normal Chinese population.

Authors:  Shujun Xin; Wenyan Man; Joachim W Fluhr; Shunpeng Song; Peter M Elias; Mao-Qiang Man
Journal:  Skin Res Technol       Date:  2010-11       Impact factor: 2.365

2.  Curcumin inhibits epigen and amphiregulin upregulated by 2,4,6-trinitrochlorobenzene associated with attenuation of skin swelling.

Authors:  Hiroyasu Sakai; Ken Sato; Fumiaki Sato; Yuki Kai; Kazutaka Mandokoro; Kenjiro Matsumoto; Shinichi Kato; Tetsuro Yumoto; Minoru Narita; Yoshihiko Chiba
Journal:  Inflamm Res       Date:  2017-04-12       Impact factor: 4.575

Review 3.  Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.

Authors:  Peter M Elias
Journal:  Biochim Biophys Acta       Date:  2013-10-12

Review 4.  The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.

Authors:  K Jovanovic; M Siebeck; R Gropp
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

5.  Knockdown of sodium channel Nax reduces dermatitis symptoms in rabbit skin.

Authors:  Jingling Zhao; Shengxian Jia; Ping Xie; Emily Friedrich; Robert D Galiano; Shaohai Qi; Renxiang Mao; Thomas A Mustoe; Seok Jong Hong
Journal:  Lab Invest       Date:  2020-01-10       Impact factor: 5.662

6.  Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis.

Authors:  Alon Y Hershko; Ryo Suzuki; Nicolas Charles; Damiana Alvarez-Errico; Jennifer L Sargent; Arian Laurence; Juan Rivera
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

7.  Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.

Authors:  George Man; Theodora M Mauro; Peggy L Kim; Melanie Hupe; Yongjiao Zhai; Richard Sun; Debbie Crumrine; Carolyn Cheung; Almudena Nuno-Gonzalez; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2014-07-31       Impact factor: 3.960

8.  Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis.

Authors:  Yutaka Hatano; Mao-Qiang Man; Yoshikazu Uchida; Debra Crumrine; Tiffany C Scharschmidt; Esther G Kim; Theodora M Mauro; Kenneth R Feingold; Peter M Elias; Walter M Holleran
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

Review 9.  Animal models of atopic dermatitis.

Authors:  Haoli Jin; Rui He; Michiko Oyoshi; Raif S Geha
Journal:  J Invest Dermatol       Date:  2009-01       Impact factor: 8.551

10.  Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus.

Authors:  Makiko Kido-Nakahara; Jörg Buddenkotte; Cordula Kempkes; Akihiko Ikoma; Ferda Cevikbas; Tasuku Akiyama; Frank Nunes; Stephan Seeliger; Burcu Hasdemir; Christian Mess; Timo Buhl; Mathias Sulk; Frank-Ulrich Müller; Dieter Metze; Nigel W Bunnett; Aditi Bhargava; Earl Carstens; Masutaka Furue; Martin Steinhoff
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.